Number of Shares
456,600.00
Current Holdings Value*
$15.01 Mil
% of Portfolio
1.15%
Total Estimate Gain
$3.26 Mil
% of Total Estimate Gain
24.27%

Fidelity Advisor Series Equity Growth Fund's Royalty Pharma PLC Holding Summary

As of 2025-05-31, FIDELITY ADVISOR SERIES I held 456,600.00 shares of Royalty Pharma PLC(RPRX), totaling $15.01 Mil. This investment constitutes 1.15% of their stock portfolio, and FIDELITY ADVISOR SERIES I now holds 0.11% of the outstanding Royalty Pharma PLC(RPRX) stock.

The initial trade took place in 2025Q1. And since then Fidelity Advisor Series Equity Growth Fund has made 2 purchases of RPRX, at an average price of $29.44, for a total of 456,600.00 shares. Based on historical transaction data and RPRX's current price of $36.59, Fidelity Advisor Series Equity Growth Fund's estimated gain on his RPRX holdings is $3.26 Mil, reflecting a 24.27% gain to date.

Fidelity Advisor Series Equity Growth Fund RPRX ($36.59) Holding Chart

Fidelity Advisor Series Equity Growth Fund RPRX ($36.59) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1